Collectively, these data suggest that dunnione alleviates breast cancer-associated lung thrombosis by inhibiting the expression of tissue factor through the NAD+/SIRT1/acetyl-NF-κB/tissue factor axis in vivo. Here, SIRT1 is linked to breast carcinoma.